Biogen makes risky bet on trial depression drug - news

next news

الجمعة، 27 نوفمبر 2020

Biogen makes risky bet on trial depression drug

The $1.5 billion deal with Sage Therapeutics will try to salvage an oral treatment that had a disappointing clinical trial



from The Boston Globe https://ift.tt/39o46gS
Damian Garde

The $1.5 billion deal with Sage Therapeutics will try to salvage an oral treatment that had a disappointing clinical trial

https://ift.tt/2HI1j6y November 28, 2020 at 12:53AM

ليست هناك تعليقات:

إرسال تعليق

Pages